Search by Drug Name or NDC
NDC 72266-0204-10 Prochlorperazine Edisylate 5 mg/mL Details
Prochlorperazine Edisylate 5 mg/mL
Prochlorperazine Edisylate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by FOSUN PHARMA USA INC. The primary component is PROCHLORPERAZINE EDISYLATE.
Product Information
| NDC | 72266-0204 |
|---|---|
| Product ID | 72266-204_fae8c785-258a-1d69-e053-6394a90afc8b |
| Associated GPIs | |
| GCN Sequence Number | 067700 |
| GCN Sequence Number Description | prochlorperazine edisylate VIAL 10 MG/2 ML INJECTION |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 30314 |
| HICL Sequence Number | 001628 |
| HICL Sequence Number Description | PROCHLORPERAZINE EDISYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Prochlorperazine Edisylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Prochlorperazine Edisylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Labeler Name | FOSUN PHARMA USA INC |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214107 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72266-0204-10 (72266020410)
| NDC Package Code | 72266-204-10 |
|---|---|
| Billing NDC | 72266020410 |
| Package | 10 VIAL in 1 CARTON (72266-204-10) / 2 mL in 1 VIAL (72266-204-01) |
| Marketing Start Date | 2023-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |